يعرض 1 - 5 نتائج من 5 نتيجة بحث عن '"hydroxysteroid 17-beta dehydrogenase 13"', وقت الاستعلام: 0.71s تنقيح النتائج
  1. 1
  2. 2
  3. 3
    دورية أكاديمية

    المساهمون: Liu, Wen-Yue, Eslam, Mohammed, Zheng, Kenneth I, Ma, Hong-Lei, Rios, Rafael S, Lv, Min-Zhi, Li, Gang, Tang, Liang-Jie, Zhu, Pei-Wu, Wang, Xiao-Dong, Byrne, Christopher D, Targher, Giovanni, George, Jacob, Zheng, Ming-Hua

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34007801; info:eu-repo/semantics/altIdentifier/wos/WOS:000644793600009; volume:9; issue:2; firstpage:194; lastpage:202; numberofpages:9; journal:JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY; http://hdl.handle.net/11562/1045011Test

  4. 4
  5. 5

    المصدر: JHEP Reports
    JHEP Reports, Vol 3, Iss 3, Pp 100284-(2021)

    مصطلحات موضوعية: SREBP, sterol response element binding protein, Alcoholic liver disease, LDs, lipid droplets, MBOAT7, membrane bound O-acyltransferase domain-containing 7, AA, arachidonic acid, PPAR, peroxisome proliferator-activated receptor, RC799-869, Disease, Review, Bioinformatics, TNF-α, tumour necrosis factor-α, Liver disease, GPR55, G protein-coupled receptor 55, Immunology and Allergy, IL-, interleukin, HFE, homeostatic iron regulator, genetics, GCKR, glucokinase regulator, PNPLA3, patatin like phospholipase domain containing 3, Fatty liver, Gastroenterology, Diseases of the digestive system. Gastroenterology, FGF19, fibroblast growth factor 19, Lipotoxicity, ASH, alcoholic steatohepatitis, PRS, polygenic risk score, FFAs, free fatty acids, HSC, hepatic stellate cells, alcoholic liver disease, IL32, TAG, triacylglycerol, precision medicine, NASH, non-alcoholic steatohepatitis, interleukin-32, HSD17B13, hydroxysteroid 17-beta dehydrogenase 13, steatohepatitis, DNL, de novo lipogenesis, MBOAT7, ER, endoplasmic reticulum, FLD, fatty liver disease, FXR, farnesoid X receptor, Internal Medicine, medicine, Genetic predisposition, PNPLA3, therapy, LPI, lysophosphatidyl-inositol, Hepatology, business.industry, cirrhosis, PUFAs, polyunsaturated fatty acids, non-alcoholic fatty liver disease, medicine.disease, Mitochondrial amidoxime reducing component 1, MARC1, mitochondrial amidoxime reducing component 1, fatty liver disease, Steatohepatitis, business, HCC, hepatocellular carcinoma, DAG, diacylglycerol